Lantheus Holdings, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Lantheus Holdings, Inc. (LNTH) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $4.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-06
- Lantheus Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $0.00.
- Lantheus Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $4.82M.
- Lantheus Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $2.62M.
- Lantheus Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $150.00K, a 138.10% increase year-over-year.
- Lantheus Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $2.77M, a 4296.83% increase from fiscal 2024.
- Lantheus Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $63.00K, a 99.79% decline from fiscal 2023.
- Lantheus Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $29.40M, a 166.78% increase from fiscal 2022.
- Lantheus Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $11.02M, a 1513.32% increase from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.82M 10-Q · filed 2026-08-06 | $7.44M derived: sum of 3 quarters · filed 2026-08-06 | $7.59M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $4.82M 10-Q · filed 2026-05-07 | $7.44M derived: sum of 2 quarters · filed 2026-05-07 | $7.59M derived: sum of 3 quarters · filed 2026-05-07 | $7.59M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.77M derived: sum of 2 quarters · filed 2026-02-26 | $2.77M derived: sum of 3 quarters · filed 2026-08-06 | $2.77M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $150.00K derived: sum of 2 quarters · filed 2026-08-06 | $150.00K 10-Q · filed 2025-11-06 | $150.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $150.00K 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $63.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | $150.00K 10-Q · filed 2025-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $63.00K derived: sum of 3 quarters · filed 2026-05-07 | $63.00K derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $63.00K derived: sum of 2 quarters · filed 2026-02-26 | $63.00K derived: sum of 3 quarters · filed 2026-02-26 | $63.00K 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $63.00K derived: sum of 2 quarters · filed 2025-11-06 | $63.00K 10-Q · filed 2025-11-06 | -$166.00K derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | -$229.00K derived: sum of 3 quarters · filed 2026-02-26 | |||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-07 | -$229.00K derived: sum of 2 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $29.40M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $29.63M 10-Q · filed 2024-11-06 | |||||
| 2022-12-31 | $11.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $11.02M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-02 | |||||
| 2021-12-31 | $683.00K 10-K · filed 2024-02-22 | |||||
| 2020-12-31 | $19.21M 10-K · filed 2022-02-24 | |||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | |||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $0.00 10-Q · filed 2019-07-25 | ||||
| 2019-03-31 | $0.00 10-Q · filed 2019-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |